Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Hepatic tumors].

K Moser, C Dittrich, P Pirich

    Acta Medica Austriaca
    |January 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    This study reviews liver cancer epidemiology, diagnosis, and treatment. It highlights advanced intraarterial and intravenous cytostatic perfusion therapies as promising alternatives to conventional chemotherapy for liver tumors.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Reply to the letter to the editor 'Integrating communication as a core skill in the global curriculum for medical oncology' by Horlait et al.

    Annals of oncology : official journal of the European Society for Medical Oncology·2017
    Same author

    ESMO/ASCO recommendations for a Global Curriculum (GC) in medical oncology-edition 2016.

    Annals of oncology : official journal of the European Society for Medical Oncology·2016
    Same author

    An ESMO-EORTC position paper on the EU clinical trials regulation and EMA's transparency policy: making European research more competitive again.

    Annals of oncology : official journal of the European Society for Medical Oncology·2015
    Same author

    Combined chemoradiotherapy with gemcitabine in patients with locally advanced inoperable transitional cell carcinoma of the urinary bladder and/or in patients ineligible for surgery: a phase I trial.

    Annals of oncology : official journal of the European Society for Medical Oncology·2014
    Same author

    Disposition of Erlotinib and Its Metabolite OSI420 in a Patient with High Bilirubin Levels.

    Case reports in oncology·2014
    Same author

    Gender-specific differences in energy metabolism during the initial phase of critical illness.

    European journal of clinical nutrition·2014
    Same journal

    [Gestational diabetes mellitus].

    Acta medica Austriaca·2005
    Same journal

    [Diagnosis, therapy and follow-up of diabetic eye diseases].

    Acta medica Austriaca·2005
    Same journal

    [Diabetic nephropathy].

    Acta medica Austriaca·2005
    Same journal

    [The diabetic foot].

    Acta medica Austriaca·2005
    Same journal

    [Diabetic neuropathy].

    Acta medica Austriaca·2005
    Same journal

    [Inhibition of platelet aggregation].

    Acta medica Austriaca·2005
    See all related articles

    Area of Science:

    • Hepatology
    • Oncology
    • Medical Science

    Background:

    • Primary hepatomas and secondary liver tumors present significant clinical challenges.
    • Conventional chemotherapy for liver malignancies often yields unsatisfactory outcomes.
    • Advanced therapeutic strategies are needed to improve patient prognosis.

    Purpose of the Study:

    • To discuss the epidemiology, pathophysiology, diagnosis, and treatment of primary and secondary liver tumors.
    • To emphasize novel cytostatic perfusion techniques for liver cancer treatment.
    • To present clinical and laboratory data on these advanced therapies.

    Main Methods:

    • Review of epidemiological and pathophysiological data for liver tumors.
    • Analysis of laboratory diagnostic methods.

    Related Experiment Videos

  • Evaluation of conventional chemotherapy outcomes.
  • Detailed examination of intraarterial and intravenous cytostatic perfusion techniques via hepatic artery and portal vein.
  • Presentation of original clinical and laboratory findings.

    • Main Results:

    • Conventional chemotherapy for liver tumors shows limited efficacy.
    • Intraarterial and intravenous cytostatic perfusion represent advanced therapeutic options.
    • The study presents novel data on the application and outcomes of these perfusion methods.
    • These methods offer potential for improved treatment of primary and secondary liver tumors.

    Conclusions:

    • Novel cytostatic perfusion therapies show promise for liver cancer treatment.
    • These advanced methods may overcome limitations of conventional chemotherapy.
    • Further clinical and laboratory investigation is warranted to optimize these liver tumor treatments.